Atara Biotherapeutics, Inc.
ATRA· Nasdaq
Released May 6, 2016, after the close
10-Q filed May 6, 2016, 36 days after period end · 0001564590-16-018294
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|
| Net Income | -$16.56M | -$9.16M | -$7.05M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Atara Biotherapeutics, Inc. · CIK 1604464 · Engraved from SEC EDGAR
ended Mar 31, 2016 · filed May 6, 2016 · 36 d after period end
+8.9% from the close of May 6, 2016 to the close of May 9, 2016, the first after the release.